Status: Not yet recruiting
Chaigui Longmu Ejiao Paste for Ischemic Heart Disease
This study explores whether Chaigui Longmu Ejiao Paste can reduce the average weekly number of angina attacks in patients with ischemic heart disease after 8 weeks of treatment, using Chaigui Longmu Paste without Ejiao as a parallel control and incorporating a synthesized external control.
Participants needed: 60
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Longhua HospitalUpdated: Mar 17, 2026Locations: 1
Eligibility criteria
Age 18-75 years, both sexes eligible; [+4]
Acute coronary syndrome or patients requiring emergency revascularization; [+8]